Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)

BVMF:PFRM3 Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	263.54	229.55	193.74	183.26	188.52	371.79
Cash & Short-Term Investments	263.54	229.55	193.74	183.26	188.52	371.79
Cash Growth	13.95%	18.48%	5.72%	-2.79%	-49.30%	64.64%
Accounts Receivable	1,342	1,394	1,187	1,044	831.43	761.96
Other Receivables	542.23	535.83	600.78	498.23	448.16	403.15
Receivables	1,884	1,930	1,788	1,542	1,280	1,165
Inventory	1,762	1,820	1,528	1,236	1,085	903.84
Prepaid Expenses	12.81	12.26	10.43	6.61	8.72	9.32
Other Current Assets	34.48	28.25	19.66	13.16	20.55	34.08
Total Current Assets	3,957	4,020	3,539	2,980	2,582	2,484
Property, Plant & Equipment	767.48	674.18	535.59	507	519.02	392.62
Long-Term Investments	1.91	2.04	2.01	1.99	-	36.46
Goodwill	482.15	486.28	483.16	488.01	495.02	500.58
Other Intangible Assets	151.26	143.04	134.74	131.47	129.31	123.89
Long-Term Deferred Tax Assets	224.98	234.13	184.1	177.08	163.7	121.86
Other Long-Term Assets	51.38	56.48	58.96	78.96	143.84	101.51
Total Assets	5,636	5,616	4,938	4,365	4,033	3,761
Accounts Payable	2,149	2,195	1,820	1,486	1,286	1,146
Accrued Expenses	106.97	91.68	69.29	147.6	119.73	130.38
Current Portion of Long-Term Debt	414.84	248.54	206.28	131.02	117.65	167.47
Current Portion of Leases	116.54	110.67	92.51	90.91	89.18	66.75
Current Income Taxes Payable	139.05	130.24	106.65	0.18	0.15	0.08
Current Unearned Revenue	28.13	109.51	49.37	21.51	46.54	-
Other Current Liabilities	102.46	103.14	102.07	79.48	57.22	33.51
Total Current Liabilities	3,057	2,989	2,447	1,956	1,717	1,544
Long-Term Debt	377.28	551.18	573.63	532.65	440.8	433.64
Long-Term Leases	391.12	336.32	271.28	269.62	299.25	232.86
Long-Term Deferred Tax Liabilities	54.48	82.12	40.22	41.42	38.06	27.38
Other Long-Term Liabilities	83.55	71.66	67.13	54.33	62.02	88.11
Total Liabilities	3,964	4,030	3,399	2,854	2,557	2,326
Common Stock	918.66	918.66	1,044	1,044	1,044	1,044
Retained Earnings	304.27	224.15	180.07	156.97	97.35	52.33
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37	-16.37
Comprehensive Income & Other	178.98	176.66	40.98	6.74	-38.58	-33.31
Total Common Equity	1,386	1,303	1,248	1,191	1,086	1,046
Minority Interest	286.87	282.72	290.68	319.58	389.82	388.9
Shareholders' Equity	1,672	1,586	1,539	1,511	1,476	1,435
Total Liabilities & Equity	5,636	5,616	4,938	4,365	4,033	3,761
Total Debt	1,300	1,247	1,144	1,024	946.88	900.72
Net Cash (Debt)	-1,036	-1,017	-949.96	-840.94	-758.37	-528.93
Net Cash Per Share	-8.45	-8.30	-7.75	-6.86	-6.19	-4.31
Filing Date Shares Outstanding	122.61	122.61	122.61	122.61	122.61	122.61
Total Common Shares Outstanding	122.61	122.61	122.61	122.61	122.61	122.61
Working Capital	899.7	1,031	1,093	1,024	865.12	940.29
Book Value Per Share	11.30	10.63	10.18	9.71	8.86	8.53
Tangible Book Value	752.14	673.79	630.44	571.54	461.74	421.85
Tangible Book Value Per Share	6.13	5.50	5.14	4.66	3.77	3.44
Machinery	319.27	280.59	236.64	215.69	194.07	173.49
Construction In Progress	6.14	6.81	14.23	6.22	9.33	7.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.